Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Letters: Comments and Responses

Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes

Response to Farvid et al.

  1. Peter Rossing, MD, DMSC1,
  2. Mark E. Cooper, MD, PHD2 and
  3. Hans-Henrik Parving, MD, DMSC13
  1. 1Steno Diabetes Center, Gentofte, Denmark
  2. 2Baker Medical Research Institute, Danielle Alberti Memorial Centre, Melbourne, Australia
  3. 3University of Aarhus, Faculty of Health Science, Aarhus, Denmark
  1. Address correspondence to Peter Rossing, MD, DMSc, Steno Diabetes Center, Niels Steensens Vej 2, Gentofte DK-2820, Denmark. E-mail: pro{at}steno.dk
Diabetes Care 2006 Mar; 29(3): 747-748. https://doi.org/10.2337/diacare.29.03.06.dc05-2144
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Response to Farvid et al.

Recently, Farvid et al. (1) reported on the effects of dietary supplementation of physiologic doses of vitamins and/or minerals on urinary albumin excretion rate (UAER)/urinary protein excretion rate (UPER), blood pressure, and lipid profile. Although not mentioned in the article, data on blood pressure and lipids have previously been reported elsewhere (2,3).

The main finding is a significant reduction in UAER of ∼66% in the group receiving both minerals and vitamins. Although Farvid et al. claimed this to be the primary end point, it was only measured once as albumin-to-creatinine ratio in morning spot urine at baseline and after 3 months. Repeated measurements (usually at least three) are always required to obtain valid data and correct diagnosis of persistent micro- and macroalbuminuria due to a coefficient of variation of 30–50%. There is a marked discrepancy between the level of UAER (30 mg/g creatinine), suggesting microalbuminuria, and the level of UPER (1–2 g/g creatinine; equal to overt nephropathy). An inconsistent effect of mineral and vitamin supplementation on UAER and UPER was reported, suggesting a chance finding.

Furthermore, mean diastolic blood pressure in the minerals and vitamins group before treatment dropped from 94 (Table 1 in Farvid et al.) to 83 (Table 6) mmHg after exclusion of 2 of the 19 patients; this indicates an error in one of the tables, as it would only be possible if the two excluded patients had a mean diastolic blood pressure of 187 mmHg. The technique for blood pressure measurement was not stated. The conditions for the power calculation were not stated, but according to their previous reports, it was powered to detect changes in HDL cholesterol (2) and blood pressure (3).

It is claimed that the UAER findings are in accordance with the literature (refs. 14–16 in Farvid et al.). However, pharmacological doses of vitamins C and E had no or minimal effect (19%) on UAER (refs. 14,15). In contrast, a 50% reduction in UAER was reported in nine patients, applying pharmacological doses of vitamin C (ref. 16).

In conclusion, the study was not powered for realistic changes in UAER/UPER, insufficient methods for valid characterization of UAER/UPER were applied, and the effect of minerals and vitamins on UAER/UPER was not consistent, clearly suggesting a type 1 error or chance finding.

Footnotes

  • M.E.C. is a member of a steering committee for Amgen.

  • DIABETES CARE

References

  1. ↵
    Farvid MS, Jalali M, Siassi F, Hosseini M: Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 28: 2458–2464, 2005
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Farvid MS, Siassi F, Jalali M, Hosseini M, Saadat N: The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes. Diabetes Res Clin Pract 65: 21–28, 2004
    OpenUrlCrossRefPubMed
  3. ↵
    Farvid MS, Jalali M, Siassi F, Saadat N, Hosseini M: The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes. J Am Coll Nutr 23: 272–279, 2004
    OpenUrlPubMed
PreviousNext
Back to top
Diabetes Care: 29 (3)

In this Issue

March 2006, 29(3)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes
Peter Rossing, Mark E. Cooper, Hans-Henrik Parving
Diabetes Care Mar 2006, 29 (3) 747-748; DOI: 10.2337/diacare.29.03.06.dc05-2144

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes
Peter Rossing, Mark E. Cooper, Hans-Henrik Parving
Diabetes Care Mar 2006, 29 (3) 747-748; DOI: 10.2337/diacare.29.03.06.dc05-2144
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension
  • Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension
  • Increased Adiposity at Diagnosis in Younger Children With Type 1 Diabetes Does Not Persist
Show more Letters: Comments and Responses

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.